|
ELK4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.409900E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.83957999999596E-05 |
| Normal-vs-Stage2 |
1.019630E-01 |
| Normal-vs-Stage3 |
2.088400E-01 |
| Normal-vs-Stage4 |
9.368800E-01 |
| Stage1-vs-Stage2 |
4.808800E-01 |
| Stage1-vs-Stage3 |
1.248990E-01 |
| Stage1-vs-Stage4 |
3.626000E-01 |
| Stage2-vs-Stage3 |
6.505200E-01 |
| Stage2-vs-Stage4 |
5.359600E-01 |
| Stage3-vs-Stage4 |
6.894800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.046300E-04 |
| Normal-vs-AfricanAmerican |
1.233910E-04 |
| Normal-vs-Asian |
8.14989999999849E-05 |
| Caucasian-vs-AfricanAmerican |
2.698800E-01 |
| Caucasian-vs-Asian |
3.323900E-03 |
| AfricanAmerican-vs-Asian |
1.924150E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.89536999999351E-05 |
| Normal-vs-Female |
4.287400E-01 |
| Male-vs-Female |
1.479870E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.335800E-02 |
| Normal-vs-Extreme_Weight |
2.69040000000498E-06 |
| Normal-vs-Obese |
6.629900E-02 |
| Normal-vs-Extreme_Obese |
1.825980E-04 |
| Normal_Weight-vs-Extreme_Weight |
1.698990E-01 |
| Normal_Weight-vs-Obese |
5.445600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.427970E-01 |
| Extreme_Weight-vs-Obese |
7.483200E-03 |
| Extreme_Weight-vs-Extreme_Obese |
7.118600E-01 |
| Obese-vs-Extreme_Obese |
2.342400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.325200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.603700E-02 |
| Normal-vs-Age(61-80Yrs) |
4.33209999994855E-06 |
| Normal-vs-Age(81-100Yrs) |
1.25429999997539E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.642600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.185900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.385900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.259620E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.825200E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.981700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.162840E-04 |
| Normal-VS-Type2 PRCC |
8.16620000000379E-05 |
| Normal-VS-KIRP CIMP |
2.731200E-01 |
| Normal-VS-Unclassified PRCC |
2.353600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.340800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.767700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.591580E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.760100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.062200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.458180E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.48030000002297E-06 |
| Normal-vs-N1 |
5.812600E-01 |
| Normal-vs-N2 |
8.522800E-01 |
| N0-vs-N1 |
3.524300E-02 |
| N0-vs-N2 |
4.321600E-01 |
| N1-vs-N2 |
9.762800E-01 |
|
|
